| LINE ITEM (USD / %) | FY 2025
FILED 2025-09-30 | FY 2024
FILED 2024-09-30 | FY 2023
FILED 2023-09-30 |
|---|---|---|---|
| Revenue (Total Sales) | $2.32B | $2.00B | $1.67B |
| YoY Revenue Growth % | +16.1% | +19.8% | — |
| Gross Profit | $770.4M | $707.3M | — |
| Gross Margin % | 33.3% | 35.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $357.4M | $387.7M | $287.3M |
| Operating Margin % | 15.4% | 19.4% | 17.2% |
| Net Income (GAAP) | $216.2M | $246.5M | $165.5M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $260.6M | $199.6M | $215.6M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $260.6M | $199.6M | $215.6M |
| FCF Margin % | 11.2% | 10.0% | 12.9% |
| Return on Invested Capital (ROIC %) | 46.3% | 48.1% | — |
| Cash & Short-Term Equivalents | $64.1M | $49.6M | — |
| Total Debt (Short + Long Term) | $1.18B | $833.4M | — |
| Total Stockholders' Equity | -$510.7M | -$146.6M | — |